Skip to main content
|PROVIDER-PRESCRIBED|FDA-REGISTERED 503A PHARMACY|FREE SHIPPING ON QUARTERLY|CANCEL ANYTIME|PROVIDER-PRESCRIBED|FDA-REGISTERED 503A PHARMACY|FREE SHIPPING ON QUARTERLY|CANCEL ANYTIME|PROVIDER-PRESCRIBED|FDA-REGISTERED 503A PHARMACY|FREE SHIPPING ON QUARTERLY|CANCEL ANYTIME|PROVIDER-PRESCRIBED|FDA-REGISTERED 503A PHARMACY|FREE SHIPPING ON QUARTERLY|CANCEL ANYTIME
All blogsPeptide Guide

NAD+ Injections for Women: Energy, Focus, Results

The coenzyme behind the celebrity IV drips, explained for women in their thirties, forties, and fifties: what NAD+ actually does, why the "it drops with age" story is more nuanced for women than the headlines suggest, injection vs. IV vs. NMN, and what a physician-prescribed month looks like week by week.

Dr. Cory Mellon, MDReviewed by Dr. Neal Kumar, MD14 min readPublished
NAD+ is the coenzyme your mitochondria use to turn food into usable energy. Vael ships it as a ready-to-use subcutaneous injection, prescribed by a licensed physician.
NAD+ is the coenzyme your mitochondria use to turn food into usable energy. Vael ships it as a ready-to-use subcutaneous injection, prescribed by a licensed physician.

Key Takeaways

  • NAD+ is a coenzyme in every cell. Your mitochondria cannot turn food into usable energy without it, and it fuels the sirtuin enzymes that manage cellular stress.
  • NAD+ falls with age in human tissue, but a large whole-blood study found the decline is steeper in men than in women. For women, cellular demand and stress often matter as much as the calendar.
  • The best human data is on oral precursors (NMN, NR), which reliably raise blood NAD+. Direct NAD+ delivery by IV or injection has smaller studies behind it. Most of the dramatic findings are in mice.
  • Women who respond usually notice steadier daytime energy in the first two weeks and clearer focus by week three or four. Effects build with consistent use rather than arriving in one dose.
  • At Vael, NAD+ is a subcutaneous injection prescribed by a licensed physician after a health screening and compounded by an FDA-registered 503A pharmacy. It is not FDA-approved for any indication.

Quick Facts

Full name

Nicotinamide adenine dinucleotide

What it is

A coenzyme present in every living cell; required for energy production and cellular stress response

Discovered

1906, Arthur Harden and William Young, while studying yeast fermentation

Best-supported effects

Raising cellular NAD+ availability; daytime energy and mental clarity are the most commonly reported changes

How it is given at Vael

Subcutaneous injection, prescribed by a licensed physician

What ships

100 mg/mL injectable vial, a one-month supply, ready to use

What NAD+ is (and why you have never heard the whole story)

If you know NAD+ at all, it is probably from a reality-TV clinic scene or a friend describing a four-hour IV drip at a wellness spa. That is a strange introduction to a molecule that has been in biochemistry textbooks for more than a century. Nicotinamide adenine dinucleotide was identified in 1906 by two British scientists studying how yeast ferments sugar, and for most of the years since it was filed under "metabolic cofactor," essential and unglamorous.

Here is the plain version. NAD+ is a shuttle. It picks up electrons from the food you break down and hands them to your mitochondria, which use them to make ATP, the energy currency every cell spends. Every heartbeat, every thought, every mile walked runs on that hand-off. NAD+ also serves as the fuel for a family of enzymes called sirtuins, which help cells manage stress, regulate inflammation, and keep their internal clocks on schedule. Without NAD+ neither system runs, which is why the body keeps hundreds of reactions dependent on it.

What actually happens to NAD+ in women

The standard line is that NAD+ falls by half between your twenties and middle age. That figure comes mostly from tissue studies. In 2012, Massudi and colleagues measured NAD+ in human skin samples across age groups and found progressively lower levels with age, alongside higher markers of oxidative stress. That is a real finding in real human tissue, and it is the study most NAD+ marketing leans on.

Massudi H, Grant R, Braidy N, et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE. 2012;7(7):e42357. View study

But the picture for women specifically is more interesting than "it drops." In 2022 a Chinese group measured NAD+ in whole blood from more than 1,500 people and split the results by sex. Men showed a steady decline with age, steepest after 60. Women did not show the same pronounced downward slope; their blood levels stayed comparatively stable across age brackets. It is one dataset, blood rather than tissue, and it does not tell us what is happening inside your muscle or brain. Still, it is the largest direct human measurement we have, and it should make you skeptical of anyone who tells a 42-year-old woman her NAD+ is "half gone."

Each dot is the average blood NAD+ for one age bracket. The left panel (men) slopes downward; the right panel (women) is much flatter. This does not make NAD+ irrelevant for women. It means the "half gone by 40" claim rests on tissue and animal data, and what blood cannot show is the demand inside cells from sleep debt, training, and hormonal transition.

Whole-blood NAD+ concentration by age group and sex in 1,518 adults. Panel A (men) shows a steady age-related decline; panel B (women) shows comparatively stable levels across age brackets.

Yang F, Deng X, Yu Y, et al. Association of Human Whole Blood NAD+ Contents With Aging. Frontiers in Endocrinology. 2022;13:829658. · CC BY 4.0

Click image to zoom

So why do so many women in their late thirties to fifties describe exactly what NAD+ is marketed for: the 3 p.m. wall, the word that will not come, waking tired after a full night in bed? Because NAD+ is consumed by demand, not just the calendar. Enzymes that use it get busier under cellular stress, and CD38, an enzyme that breaks it down, becomes more active with age and inflammation. Short sleep, hard training, a demanding job, the perimenopause years when sleep gets less predictable for many women: all of it raises the draw on the same pool. In general terms, a woman can have a normal blood level and still have tissues running closer to the line than at 28. That is the honest case for NAD+, and it is narrower than the marketing version.

How NAD+ works inside a cell

NAD+Coenzyme

Energy hand-off

Carries electrons from broken-down food to the mitochondria, where they drive ATP production. Low NAD+ availability slows this chain, which cells experience as less usable energy.

Sirtuin fuel

Sirtuins are seven enzymes that manage cellular stress, inflammation signaling, and metabolic switching. Every one of them consumes NAD+ to work.

Clock keeping

NAD+ rises and falls on a 24-hour rhythm tied to SIRT1 and the core clock genes. This is the mechanistic reason NAD+ is usually given in the morning.

Demand and drain

Stress-response enzymes and CD38 break NAD+ down faster under inflammation and cellular damage, so the pool shrinks when demand is highest.

Why "energy" is the first thing people feel

The mitochondrial hand-off is the most direct and least controversial thing NAD+ does. When availability improves, the cells with the highest energy demand respond first: brain, heart, and skeletal muscle. It is why the earliest reports from women tend to be about the afternoon: the slump softens, the second coffee becomes optional, a 6 p.m. workout feels possible again. Your brain spends about 20 percent of your energy budget on 2 percent of your body weight, which is the mechanistic reason focus changes are reported next. Human trials with cognitive endpoints are still thin, so treat that as commonly reported rather than established.

What women tend to notice

Expectations first: NAD+ is not a stimulant, and it will not paper over four hours of sleep. Women who respond describe a lift in baseline rather than a jolt. In our experience the changes tend to arrive in this order.

Steadier daytime energy. The first and most consistent report, usually within two weeks. Mornings feel less like a negotiation and the afternoon dip is shallower. Clearer focus. By week three or four, many women report easier concentration and recall. Better recovery. Women who train notice the day after a hard session is less rough. Waking more restored is often mentioned, though NAD+ is not a sleep aid and should not be taken at night. A steadier mood floor. Not euphoria. More margin before end-of-day irritability. Subjective, and it varies a lot.

Human data vs. mouse data, honestly

This is the section most NAD+ articles skip. The evidence comes in three tiers, and they are not interchangeable.

Tier one: what happens in mice

The dramatic findings are almost all in animals. Long-term NMN in aged mice improved energy metabolism, physical activity, and eye function. These are careful studies from serious labs and they explain why the field exists. They are also mice, dosed at levels no human protocol matches, and mice are not middle-aged women.

Mills KF, Yoshida S, Stein LR, et al. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metabolism. 2016;24(6):795-806. View study

Tier two: human trials of precursors

The best human data is on oral precursors, the raw materials your cells convert into NAD+. Nicotinamide riboside (NR) taken for six weeks by healthy middle-aged and older adults raised NAD+ in circulating blood cells by about 60 percent and was well tolerated. In a small trial that matters for this audience, NMN improved muscle insulin sensitivity in postmenopausal women with prediabetes, though most other measures did not change. Precursors reliably raise the blood number. Whether that translates into feeling different is where the evidence softens, and the honest answer is "sometimes, modestly."

Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9(1):1286. View study

Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. View study

Tier three: direct NAD+ by IV or injection

Here the literature is thinnest. The best-known study is a 2019 pilot in which volunteers received a six-hour IV infusion of NAD+ while researchers tracked it in plasma and urine. Plasma NAD+ barely moved for two hours, then rose, and part of the dose left in urine as breakdown products. It showed the body takes up and processes infused NAD+, and that a fast bolus is partly wasted. It did not measure how anyone felt. Subcutaneous injection is a well-established route for peptides, and its slower absorption is the argument for it over a drip. But there are no large randomized trials of subcutaneous NAD+ on energy or focus in women. What we have is mechanism, precursor data, and clinical experience. We would rather say that than pretend otherwise.

Grant R, Berg J, Mestayer R, et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. 2019;11:257. View study

Conflicts of interest worth knowing

David Sinclair (NMN) and Charles Brenner (NR), two of the loudest voices in the field, each have financial ties to the precursor they champion and publicly disagree about the science. The loudest claims deserve the most scrutiny.

Injection vs. IV drip vs. NMN and NR

Same molecule, three ways to get it. A drip is a multi-hour appointment. A capsule is easy to forget. A daily injection sits in between, and for most women it is the version that survives a real week.

What you get

Subcutaneous NAD+ (Vael)
NAD+ itself
NAD+ IV drip
NAD+ itself
Oral NMN or NR
A precursor your cells must convert

Where it happens

Subcutaneous NAD+ (Vael)
At home, a few minutes
NAD+ IV drip
A clinic, 2 to 6 hours per session
Oral NMN or NR
At home, with a glass of water

Absorption pattern

Subcutaneous NAD+ (Vael)
Slower, steadier release from the fat layer
NAD+ IV drip
Fast bolus; a portion is cleared in urine
Oral NMN or NR
Through the gut; raises blood NAD+ reliably

Human evidence

Subcutaneous NAD+ (Vael)
Mechanism, clinical experience, no large RCTs
NAD+ IV drip
Small pilot and case data
Oral NMN or NR
Several randomized trials on blood levels

Typical cost

Subcutaneous NAD+ (Vael)
A monthly prescription
NAD+ IV drip
Several hundred dollars or more per session
Oral NMN or NR
Varies widely; supplement quality is uneven

Common complaints

Subcutaneous NAD+ (Vael)
Brief sting or warm flush at the site
NAD+ IV drip
Nausea, cramping, chest tightness if run fast
Oral NMN or NR
Few; some report stomach upset

Prescription

Subcutaneous NAD+ (Vael)
Yes, compounded by a 503A pharmacy
NAD+ IV drip
Yes, in-clinic
Oral NMN or NR
No

A realistic week-by-week timeline

NAD+ tends to show itself faster than the skin peptides because energy is downstream of everything. Response varies with baseline, sleep, and consistency. This is the arc most women describe.

Days 1-3

Learning the sting

NAD+ is known for a brief sting or warm flush during the injection. A slow push over 20 to 30 seconds and letting the vial sit out a few minutes first make a real difference. A mild headache or flushing the first day or two passes.

Weeks 1-2

Steadier energy

The most consistently reported early change: a shallower afternoon dip, mornings that start with less friction. If you are badly sleep-deprived or under-eating, this is where you find out NAD+ will not cover for that.

Weeks 3-4

Focus and recovery

Many women report clearer concentration and easier recall, and those who train notice the day after a hard session feels less heavy. Some describe waking more restored, though the evidence for sleep effects is thin.

Weeks 5-8

A new normal

Changes start feeling like your baseline. This is when most women decide whether the protocol has earned its place.

Beyond 8 weeks

Reassess with your physician

NAD+ is commonly continued rather than cycled, since the demand on the pool is ongoing. Your physician reviews your response at renewal.

Side effects, the sting, and who should wait

NAD+ is a molecule your body already makes and clears, and subcutaneous NAD+ is generally well tolerated. The thing women ask about most is the sting: a sharp or warm sensation during the injection that lasts a minute or two. It is a known quirk of NAD+ specifically, it is dose and speed dependent, and it is not a sign anything is wrong. A slower push, a site with a generous fat pad (lower abdomen or outer thigh rather than the back of the arm), and rotating at least an inch from the last spot all help.

Beyond the sting: mild redness or a small bump, a brief headache or flushing in the first days, occasional queasiness early on. Injecting late in the day can leave some women wired at bedtime, which is why morning dosing is standard. IV NAD+ has a longer list of acute effects that the slow subcutaneous route largely avoids.

Ideal for

Women in their mid-thirties through fifties whose main complaint is energy that does not match their effort: the afternoon wall, slow mornings, focus that fades by 4 p.m. Women who train and want recovery to keep pace. Women who will actually do a small daily injection five mornings a week.

Consider alternatives if

If you are pregnant, breastfeeding, or trying to conceive, NAD+ is not appropriate; there is no safety data. If you have a history of cancer, tell your physician; NAD+ supports cell metabolism broadly and the screening will weigh this carefully. If your fatigue is new, severe, or paired with other symptoms, see your regular doctor first. Thyroid, iron, and sleep problems are common in women this age and no peptide fixes them.

Fatigue deserves a real workup

Persistent tiredness in women over 35 has a long list of ordinary, testable causes. NAD+ is reasonable to try once those are ruled out, not a substitute for ruling them out. The physician screening is not a replacement for your primary care.

How a Vael NAD+ month runs

NAD+ at Vael

Route

Subcutaneous injection

Frequency

Set by your physician; commonly once daily, five days on and two off

Timing

Morning, to match the body's daily NAD+ rhythm

Dose

Per your prescription

Sites

Lower abdomen, outer thigh, upper outer glute; rotated

Vial

100 mg/mL, a one-month supply, ships ready to use

Storage

Refrigerated, 36-46°F (2-8°C); do not freeze

It starts with a short health screening. A licensed physician reviews it and decides whether NAD+ is appropriate for you; if not, nothing ships. Approved prescriptions are compounded by an FDA-registered 503A pharmacy and delivered cold, ready to use, with dosing instructions. You draw the prescribed amount straight from the vial. If injecting is new to you, our at-home injection guide walks through it, and the slow-push technique matters more for NAD+ than anything else we ship.

NAD+ is also one half of The Vitality Stack, paired with glutathione for women whose goal is energy and a clearer complexion together, and part of The Total Renewal Stack with GHK-Cu. If you are not sure which fits, the 60-second quiz is a reasonable place to start. For the bigger picture on energy and skin during the perimenopause years, see this overview.

Common questions

Most women who respond notice steadier daytime energy within the first two weeks and clearer focus by week three or four. Effects build with consistent daily use rather than arriving in a single dose. If nothing has changed after six to eight weeks of consistent use, it is worth discussing with your physician at renewal.

NAD+ has a reputation for a brief sting or warm flush during the injection that fades within a minute or two. It is speed and volume dependent. Injecting slowly over 20 to 30 seconds, using a site with a good fat pad like the lower abdomen or outer thigh, and letting the vial reach room temperature reduce it noticeably.

Subcutaneously, into the fat layer beneath the skin. The lower abdomen at least two inches from the navel is the most common site. The outer thigh and upper outer glute are good alternatives. The back of the arm is often the thinnest site and tends to sting more with NAD+, so many women use it least. Rotate at least an inch from the last spot each time.

Same molecule. An IV floods the bloodstream fast, part is cleared in urine, and it takes hours in a clinic. A subcutaneous injection absorbs slowly and takes minutes at home. For ongoing use the injection is more practical. Neither route has large randomized trials behind it.

NMN and NR are precursors, raw materials your cells convert into NAD+. Oral precursors have the best human data for raising blood NAD+ levels. Injectable NAD+ delivers the finished molecule directly. You can take a precursor alongside the injection; they enter the pathway at different points.

Tissue studies show NAD+ falling with age, but the largest whole-blood study found the decline steeper in men, with women's levels comparatively stable. For women, demand often matters more: short sleep, training, inflammation, and the hormonal transition years all draw the pool down faster.

Mostly local and brief: the injection sting, mild redness or a small bump, and in the first days a headache, flushing, or mild queasiness. Injecting late in the day can make some women feel wired at night, which is why morning dosing is standard. NAD+ is not appropriate in pregnancy or breastfeeding.

Vael ships NAD+ fully reconstituted and ready to use. Store refrigerated 36-46°F. Do not freeze. Keep the vial upright and away from light, and inspect it before each use; if you see particles, cloudiness, or a color change, do not use it and contact support.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

Ready to start NAD+?

Physician-prescribed NAD+, compounded by an FDA-registered 503A pharmacy and shipped ready to use.

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA Vael. All rights reserved.

Ready to start NAD+?

Physician-prescribed NAD+, compounded by an FDA-registered 503A pharmacy and shipped ready to use. From $229/month.